MicroRNA (miRNA) Market Size, Share & Trends Analysis Report By Research Tools, By Application (Cancer, Neurological Disease, Immunological Disorder, Infectious Diseases) By End-use, And Segment Forecasts, 2018 - 2025

1. FollowUs:
MicroRNA (miRNA)Market Global Share, Trend, Segmentation And
Forecast To 2025| Grand View Research, Inc
The global microRNA (miRNA) market size is expectedto reach USD 626.27 millionby 2025, according to a new
report by Grand ViewResearch, Inc., posting a CAGR of 18.6% during the forecast period.A significant role of
microRNAs in regulating gene expression.Theirrapid adoption in developmentof diagnostic & prognostic tools for
various cancer typesis anticipated to provide a fillipto the market.
Recent innovationsin miRNA applications such as their use as potential biomarkers in advanced diagnostics have
accelerated new product development.Basedon existingtechnologiesused in gene analysis such as microarrays,
qRT-PCR, and sequencing,new products are being developedforbetter usage of miRNA.These are designedto
overcome challengesfaced when working withmiRNA.
Investmentsin developmentof therapeutics & diagnostic tests based on miRNAshave increased tremendouslyover
past fewyears. Regulus Therapeutics, Rosetta Genomics, AlnylamPharmaceuticals, miRagen Therapeutics, and
Mirna Therapeutics are some major companies involvedin the developmentof RNA-basedtherapeutics. These
players are involvedin strategic partnerships to enhance their capabilities.For instance, in February 2018, STA
Pharmaceutical Co., Ltd., a manufacturer of technology platform for small molecule pharmaceutical developme nt
signedan agreement with RegulusTherapeutics to provide its manufacturing facility to the company.
Academic & governmentresearch organizations are key revenue contributors as large number of microRNA research
is carried out in these institutes.However,rising interest of biotech & pharmaceutical companies in miRNAs as
biomarkers, especiallyincancer screening,is providing a significantpush to the market. MiRNA regulatinggene
expressionsin Alzheimer’sdiseases,AutismSpectrum Disorders (ASD), Schizophrenia,and Parkinson’sdiseaseshave
beenidentified.Soaring needfor easy diagnosis of these diseasesis projectedto further increase demand for miRNA
research tools.
“The globalmicroRNA(miRNA)marketsizewasestimatedat USD 160.5million
in 2017. It is projected to rise at a CAGR of 18.6% over the forecast period.”

2. FollowUs:
Instruments used in miRNA analysis, especiallythose based on advanced technology, are expensive.However,
processes performedare available at reasonable prices through service providers. MiRNA analysis is a part of
genomic analysis,thereby many service providers for the genomics market have extendedtheirservice offeringto
this market as well.Novel approaches for handling targeted deliveryof miRNAsare beingdeveloped.Nanoparticle -
based deliveryand miRNA conjugation with other small moleculesare few of the potential approaches being
studied.Focus on developmentof approaches to overcome challengesin the deliveryof miRNA therapeutics is
estimatedto propel the market over the forecast period.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/microrna-market
Further Key Findings from the Report Suggest:
 Growing competitionamong miRNA-basedtherapeuticcompanies to developtests& biomarkers for clinical
use is likelyto boost the demand for miRNA detection services
 Rapid high-qualityresults coupled withdecliningsequencing prices are poised to drive adoption of NGS
services for miRNA functional studies.
 North America dominatedthe microRNA market owing to presence of large scale genetic research programs
being conducted by universitiesinthe U.S. and Canada. MiRNA profilingstudies in these regions are
supported by international publicfunctional genomic data repositoriessuch as Gene Expression Omnibus
 Asia Pacific is projected to witnessphenomenal CAGR owing to rapid progress in precisionmedicine &
genomics. Owingto the immense potential in APAC, international players are adopting M&A strategies to
consolidate theirposition in the region
 The market is moderatelyconsolidated and competitive in nature due to presence of several multinational
players
 Some key companiespresent in the market are Thermofisher Scientific(Life Technologies);Agilent
Technologies;Merck KGaA; QIAGEN (Exiqon);and NanoString Technologies;Inc. The prominence of these
players can be attributed to their well-establishedtechnical capabilitiesinother fieldsof biotechnology.
Grand ViewResearch has segmentedthe global microRNA market on the basis of research scope, application, end-
use, and region:
MicroRNA Research Tools Outlook (Revenue, USD Million, 2014 - 2025)
 Services
o Sample collection
o Whole Blood
o Serum
o Plasma
o miRNA cDNA Synthesis
o Profiling& Purification
o Detection
o Functional Studies

3. FollowUs:
o NGS
o Microarray
o Real Time PCR
o Others
o Products
o Instruments
o Kits, Reagents, & Consumables
o Isolation & Purification
o Quantification & Detection
o Functional Analysis
o Others
MicroRNA Application Outlook (Revenue, USD Million, 2014 - 2025)
 Cancer
 InfectiousDiseases
 Immunological Disorder
 Cardiovascular Disease
 Neurological Disease
 Others
MicroRNA End-use Outlook (Revenue, USD Million, 2014 - 2025)
 Biotechnologyand Pharmaceutical Companies
 Academic & Government Research Institutes
 Others
MicroRNA Regional Outlook (Revenue, USD Million, 2014 - 2025)
 North America
o U.S.
o Canada
 Europe
o Germany
o UK
 Asia Pacific
o Japan
o China

4. FollowUs:
 Latin America
o Brazil
 Middle East & Africa
o South Africa
Browse Related Category Reports @ www.grandviewresearch.com/industry/healthcare-it
Table of Content of MicroRNA (miRNA) Market
Chapter 1 Executive Summary
Chapter 2 ResearchMethodology
2.1 Information procurement
2.1.1 Purchaseddatabase:
2.1.2 GVR’sInternal Database
2.2 InformationorData Analysis
2.3 Market Formulation&Validation
2.4 ApproachesforMarketEstimation
2.4.1 Approach1: CommodityFlow&BottomUp Approach
2.4.2 Approach2: Top Downand ParentMarket Analysis
Chapter 3 microRNAMarket Variables,Trends& Scope
3.1 Market Segmentation&Scope
3.1.1 Market driveranalysis
3.1.1.1 Recentinnovationsinapplicationsof miRNAs
3.1.1.1.1 Increasedadoptionforuse asa biomarker
3.1.1.1.2 Therapeuticapplications
3.1.1.2 High investmentsinmiRNA andrisingR&Dinitiativesfordevelopmentof new diagnostictests&
therapeutics
3.1.1.3 Successof miRNA inclinical trials
3.1.1.4 Technological advancementstosupportnucleicacidstudies
3.1.1.5 Exponentiallydecliningcostof sequencing
3.1.2 Market restraintanalysis
3.1.2.1 High cost associatedwithmicroRNA kitsandotherproducts
3.1.2.2 ChallengesinhandlingRNA &in-house developmentof assaysformicroRNA detection

5. FollowUs:
3.1.2.3 Poor reproducibilityof researchandspecificityof products
3.1.2.4 Limitedlife science researchinfrastructure inemergingmarkets
3.1.2.5 Needof skilledpersonnel
3.2 Penetration&GrowthProspectMappingforApplication,2017
3.3 PatentReview/NewDevelopments
3.4 MicroRNA-SWOTAnalysis,ByFactor(Political &Legal,EconomicAndTechnological)
3.5 IndustryAnalysis –Porter’s
Chapter 4 microRNAMarket: Products & ServicesEstimates & Trend Analysis
4.1 Global MicroRNA Market:Products& ServicesMovementAnalysis,2017 & 2025
4.2 Services
4.2.1 Global servicesmarket,2014 - 2025 (USD Million)
4.2.2 Sample collection
4.2.2.1 Global miRNA sample collectionmarket,2014 - 2025 (USD Million)
4.2.2.2 Whole blood
4.2.2.2.1 Global whole bloodcollectionformiRNA market,2014 - 2025 (USD Million)
4.2.2.3 Serum
4.2.2.3.1 Global serumcollectionformiRNA market,2014 - 2025 (USD Million)
4.2.2.4 Plasma
4.2.2.4.1 Global plasmacollectionformiRNA market,2014 - 2025 (USD Million)
4.2.3 miRNA cDNA Synthesis
4.2.3.1 Global miRNA cDNA synthesismarket,2014 - 2025 (USD Million)
4.2.4 miRNA Profiling&Purification
4.2.4.1 Global miRNA profiling&purificationmarket,2014 - 2025 (USD Million)
4.2.5 Detection
4.2.5.1 Global miRNA detectionmarket,2014 - 2025 (USD Million)
4.2.6 miRNA functional studies
4.2.6.1 Global miRNA functional studiesmarket,2014 - 2025 (USD Million)
4.2.6.2 NextGenerationSequencing(NGS)
4.2.6.2.1 Global miRNA NGSmarket,2014 - 2025 (USD Million)
4.2.6.3 Microarray
4.2.6.3.1 Global miRNA microarraymarket,2014 - 2025 (USD Million)
4.2.6.4 Real Time – PCR (RT-PCR)

6. FollowUs:
4.2.6.4.1 Global miRNA detectionusingRT-PCRservicesmarket,2014 - 2025 (USD Million)
4.2.6.5 Others
4.2.6.5.1 Global miRNA detectionusingotherfunctional analysisservices market,2014 - 2025 (USD
Million)
4.3 Products
4.3.1 Global miRNA productsmarket,2014 - 2025 (USD Million)
4.3.2 Instruments
4.3.2.1 Global miRNA instrumentsmarket, 2014 - 2025 (USD Million)
4.3.3 Consumables
4.3.3.1 Global miRNA consumablesmarket,2014 - 2025 (USDMillion)
4.3.3.2 Isolation&purification
4.3.3.2.1 Global miRNA isolation&purificationconsumablesmarket,2014 - 2025 (USD Million)
4.3.3.3 Quantification&detection
4.3.3.3.1 Global miRNA quantification&detectionconsumablesmarket,2014 - 2025 (USD Million)
4.3.3.4 Functional analysis
4.3.3.4.1 Global miRNA functional analysisconsumablesmarket,2014 - 2025 (USD Million)
4.3.3.5 Other consumables
4.3.3.5.1 Global miRNA otherconsumablesmarket,2014 - 2025 (USD Million)
Chapter 5 microRNAMarket: ApplicationEstimates& Trend Analysis
5.1 Global Micro RNA Market: ApplicationMovementAnalysis,2017 & 2025
5.2 Cancer
5.2.1 Global miRNA cancermarket,2014 - 2025 (USD Million)
5.3 InfectiousDiseases
5.3.1 Global miRNA infectiousdiseasesmarket,2014 - 2025 (USD Million)
5.4 Immunological Disorder
5.4.1 Global miRNA immunological disordermarket,2014 - 2025 (USD Million)
5.5 CardiovascularDisease
5.5.1 Global miRNA cardiovasculardisease market,2014 - 2025 (USD Million)
5.6 Neurological Disease
5.6.1 Global miRNA neurological disease market,2014 - 2025 (USD Million)
5.7 Others
5.7.1 Global miRNA otherapplicationsmarket,2014 - 2025 (USD Million)

7. FollowUs:
Chapter 6 microRNAMarket: End-use Estimates& Trend Analysis
6.1 Global MicroRNA Market:End-use MovementAnalysis,2017 & 2025
6.2 Biotechnology&Pharmaceutical Companies
6.2.1 Global biotechnology&pharmaceutical companiesmarket,2014 - 2025 (USD Million)
6.3 Academic&GovernmentResearchInstitutes
6.3.1 Global academic& governmentresearchinstitutesmarket,2014 - 2025 (USD Million)
6.4 Otherend-users
6.4.1 Global otherend-use market,2014 - 2025 (USD Million)
Chapter 7 microRNAMarket: Regional Estimates& Trend Analysis,by Product & Services,Applications,& End User
7.1 MicroRNA Market Share By Region,2017 & 2025
7.2 NorthAmerica
7.2.1 NorthAmericamicroRNA market,2014 - 2025 (USD Million)
7.2.2 U.S.
7.2.2.1 U.S. microRNA market, byproducts& services2014 - 2025 (USD Million)
7.2.2.2 U.S. microRNA market,byapplication2014 - 2025 (USDMillion)
7.2.2.3 U.S. microRNA market,byend-user2014 - 2025 (USD Million)
7.2.3 Canada
7.2.3.1 Canada microRNA market,byproducts& services2014 - 2025 (USD Million)
7.2.3.2 Canada microRNA market,byapplication2014 - 2025 (USD Million)
7.2.3.3 Canada microRNA market,byend-user2014 - 2025 (USD Million)
7.3 Europe
7.3.1 Europe microRNA market,2014 - 2025 (USD Million)
7.3.2 Germany
7.3.2.1 Gerrmany microRNA market,byproducts& services2014 - 2025 (USD Million)
7.3.2.2 Gerrmany microRNA market,byapplication2014 - 2025 (USD Million)
7.3.2.3 Gerrmany microRNA market,byend-user2014 - 2025 (USD Million)
7.3.3 U.K.
7.3.3.1 U.K. microRNA market,byproducts& services2014 - 2025 (USD Million)
7.3.3.2 U.K. microRNA market,byapplication2014 - 2025 (USD Million)
7.3.3.3 U.K. microRNA market,byend-user2014 - 2025 (USD Million)
7.4 AsiaPacific
7.4.1 AsiaPacificmicroRNA market,2014 - 2025 (USD Million)

8. FollowUs:
7.4.2 Japan
7.4.2.1 Japan microRNA market,byproducts& services2014 - 2025 (USD Million)
7.4.2.2 Japan microRNA market,byapplication2014 - 2025 (USD Million)
7.4.2.3 Japan microRNA market,byend-user2014 - 2025 (USD Million)
7.4.3 China
7.4.3.1 ChinamicroRNA market,byproducts& services2014 - 2025 (USD Million)
7.4.3.2 ChinamicroRNA market,byapplication2014 - 2025 (USD Million)
7.4.3.3 ChinamicroRNA market,byend-user2014 - 2025 (USDMillion)
7.5 LatinAmerica
7.5.1 Latin AmericamicroRNA market,2014 - 2025 (USD Million)
7.5.2 Brazil
7.5.2.1 Brazil microRNA market,byproducts& services2014 - 2025 (USD Million)
7.5.2.2 Brazil microRNA market,byapplication2014 - 2025 (USD Million)
7.5.2.3 Brazil microRNA market,byend-user2014 - 2025 (USDMillion)
7.6 Middle East& Africa(MEA)
7.6.1 Middle East & AfricamicroRNA market,2014 - 2025 (USD Million)
7.6.2 SouthAfrica
7.6.2.1 South AfricamicroRNA market,byproducts& services2014 - 2025 (USDMillion)
7.6.2.2 South AfricamicroRNA market,byapplication2014 - 2025 (USD Million)
7.6.2.3 South AfricamicroRNA market,byend-user2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 StrategyFramework
8.2 Market ParticipationCategorization
8.3 Listof Companies
8.4 CompanyProfiles
8.4.1 Merck KGaA
8.4.1.1 Companyoverview
8.4.1.1.1 Sigma-AldrichCo.LLC
8.4.1.2 Financial performance
8.4.1.2.1 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategicinitiatives

9. FollowUs:
8.4.2 QIAGEN
8.4.2.1 Companyoverview
8.4.2.1.1 Exiqon
8.4.2.2 Financial performance
8.4.2.2.1 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategicinitiatives
8.4.3 Dharmacon,a HorizonDiscoveryGroupCo.
8.4.3.1 Companyoverview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.4 ThermoFisherScientific,Inc.
8.4.4.1 Companyoverview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategicinitiatives
8.4.5 Synlogic
8.4.5.1 Companyoverview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategicinitiatives
8.4.6 GeneCopoeia,Inc.
8.4.6.1 Companyoverview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.7 NewEnglandBiolabs
8.4.7.1 Companyoverview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategicinitiatives
8.4.8 Quantabio
8.4.8.1 Companyoverview

10. FollowUs:
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategicinitiatives
8.4.9 NanoStringTechnologies,Inc.
8.4.9.1 Companyoverview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategicinitiatives
8.4.10 BioGenex
8.4.10.1 Companyoverview
8.4.10.2 Financial performance
8.4.10.3 Productbenchmarking
8.4.10.4 Strategicinitiatives
8.4.11 SeqMatic LLC
8.4.11.1 Companyoverview
8.4.11.2 Financial performance
8.4.11.3 Productbenchmarking
8.4.12 Miltenyi Biotec
8.4.12.1 Company overview
8.4.12.2 Financial performance
8.4.12.3 Productbenchmarking
8.4.13 SistemicScotlandLimited
8.4.13.1 Companyoverview
8.4.13.2 Financial performance
8.4.13.3 Productbenchmarking
8.4.13.4 Strategicinitiatives
8.4.14 BiodynamicsLaboratory,Inc.
8.4.14.1 Companyoverview
8.4.14.2 Financial performance
8.4.14.3 Productbenchmarking
8.4.15 OriGene Technologies,Inc.
8.4.15.1 Companyoverview

11. FollowUs:
8.4.15.2 Financial performance
8.4.15.3 Productbenchmarking
8.4.15.4 Strategicinitiatives
About Us:
Grand ViewResearch, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To helpclients make informed business decisions, the company offers
market intelligence studiesensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist,USA
Grand ViewResearch, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com